Dana-Farber to hold a discussion for cancer patients and survivors about the Covid-19 vaccine

Posted date

Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2021 at 5 p.m. EST. Physicians from Dana-Farber will discuss common concerns and questions cancer patients and survivors have about the vaccine. 

“While much information is publicly available, we know that cancer patients and survivors, and their families, have specific questions and want detailed information about the implications and availability of the vaccine,” said Steven R. Singer, chief communications officer, Dana-Farber. “We have an excellent panel of specialists and hope that this discussion will be a good resource for them.”

The discussion will be led by Dana-Farber leaders, including:

Following brief presentations, the panelists will answer questions from attendees.

Here is the link to participate in the discussion, and attendees may submit questions for the speakers in advance.

A recording of the Forum will be posted on the Dana-Farber website, where additional information about Covid-19 vaccines for cancer patients is located.  

News Category
Related Doctors and Researchers

Media Contacts

If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email media@dfci.harvard.edu.

The Media Team cannot respond to patient inquiries. For more information, please see Contact Us.